Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Stock Websites
Top Gainers/ Losers/ Active Stocks
Dividend Stocks
ChatGPT Stocks
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Investment Ideas
Research Tools
Stock Screener
ETF Screener
Popular
Compare Stocks
Compare ETFs
Trending Stocks
Technical Analysis Screener
Penny Stock Screener
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compound Interest Calculator
New
Mortgage Calculator
New
Auto Loan Calculator
New
Research Tools
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Portfolio
News
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us
More
Plans
News
Smart Portfolio
Expert Center
TipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
ETF Center
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed Tools
Try Now
Ideas
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Stock Websites
Top Gainers/ Losers/ Active Stocks
Dividend Stocks
ChatGPT Stocks
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Tools
Research Tools
Stock Screener
ETF Screener
Popular
Compare Stocks
Compare ETFs
Trending Stocks
Technical Analysis Screener
Penny Stock Screener
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compound Interest Calculator
New
Mortgage Calculator
New
Auto Loan Calculator
New
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Enterprise Solutions
Plans & Pricing
More
Education
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us
TIL
Stock Latest News
The Fly
Instil Bio reports Q2 EPS (11c), consensus (16c)
2M ago
TIL
Press Releases
Instil Bio Reports Second Quarter 2023 Financial Results and Provides Corporate Update
2M ago
TIL
The Fly
Instil Bio initiated with a Buy at H.C. Wainwright
3M ago
TIL
Press Releases
Instil Bio Announces Oral Presentation of ITIL-306 Preclinical Data at British Society for Gene and Cell Therapy Annual Conference
3M ago
TIL
The Fly
Instil Bio reports Q4 EPS (41c), consensus (41c)
6M ago
TIL
Press Releases
Instil Bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
6M ago
TIL
Press Releases
Instil Bio Announces Extension of Cash Runway Beyond 2026 with the Consolidation of R&D Operations to its Manchester, U.K. Site
8M ago
TIL
The Fly
Instil Bio extends cash runway with consolidation of R&D operations
8M ago
TIL
The Fly
Instil Bio sees cash runway into 2025
9M ago
TIL
The Fly
Instil Bio resumes clinical trial of ITIL-306 in lung, ovarian, renal cancer
9M ago
TIL
Press Releases
Instil Bio Announces Resumption of Clinical Trial of CoStAR-TIL Candidate ITIL-306 in Lung, Ovarian, and Renal Cancer
9M ago
TIL
The Fly
Instil Bio price target lowered to $5 from $14 at Baird
10M ago
TIL
The Fly
Instil Bio discontinues ITIL-168 clinical programs
10M ago
TIL
The Fly
Instil Bio prioritizes CoStAR-TIL program, reduces headcount by 60%
10M ago
TIL
The Fly
Instil Bio treatment of stage IB2 to IV cervical cancer granted orphan status
10M ago
TIL
The Fly
Instil Bio reports Q3 EPS (43c), consensus (44c)
11M ago
TIL
Press Releases
Instil Bio Reports Third Quarter 2022 Financial Results and Provides Corporate Update
11M ago
TIL
The Fly
Society for Immunotherapy of Cancer to hold a meeting
11M ago
LH
BMY
The Fly
Society for Immunotherapy of Cancer to hold a meeting
11M ago
LH
BMY
The Fly
Instil Bio announces poster presentations of CoSTAR platform
11M ago
TIL
Market News
Instil Bio Pauses Clinical Trial Enrollments
11M ago
TIL
Press Releases
Instil Bio Announces Voluntary Pause of Enrollment in Ongoing Clinical Trials Related to Manufacturing
11M ago
TIL
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.